Long-term effect of eplerenone treatment in children with chronic allograft nephropathy.
Esra BaskınMeraj Alam SiddiquiKaan Savas GullerogluBinnaz Handan ÖzdemirAysun Çaltık YılmazMeriç Yavuz ÇolakAydıncan AkdurEbru Hatice Ayvazoğlu SoyGökhan MorayMehmet HaberalPublished in: Pediatric transplantation (2023)
The long-term eplerenone administration blunted the chronic allograft nephropathy by maintaining a stable eGFR levels and decreasing urine protein-creatinine ratio. Eplerenone associated hyperkalemia was not observed in our study.